# Ciprofloxacin

NDC: 16252-515
Generic name: Ciprofloxacin
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20061101
Marketing ended: 20270831
FDA application: ANDA076794

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16252-515"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16252-515
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e4402d4-e0d3-9846-3e81-ed46f34137fe